Corticosteroid Alternative Demonstrates High Rate of MS Relapse Resolution
January 16th 2020Findings from a large scale study of multiple sclerosis treatments showed greater levels of relapse resolution with oral corticosteroids and repository corticotropin injections compared to other treatments.
Will Gepants and Monoclonal Antibodies Be Used in Tandem for Migraine?
January 16th 2020After first-step data suggested that one small molecule CGRP receptor antagonist and a monoclonal antibody against CGRP were successful and safe together in migraine. One of the study authors, Kathleen Mullin, MD, discussed the data.
Relief for MS Drug Prices Is Not Coming Soon, Report Suggests
January 16th 2020New data from a report on US Medicaid program spending suggests that spending on disease-modifying therapies has more than doubled over a recent 7-year stretch, with no expected help from generic competition coming soon.
Tapping Into Individualized Risk Prediction in Epilepsy Surgery Candidates
January 15th 2020Lara Jehi, MD, professor of neurology and an epilepsy specialist at the Cleveland Clinic Lerner College of Medicine, spoke to her work on individualized risk assessments for epilepsy surgery candidates and the impact it can have for both physicians and patients alike.
Erenumab High Responders Benefit Exceptionally In Chronic Migraine Treatment
January 13th 2020Those achieving ≥50% response attained migraine reductions nearly double that of the full cohort, with data possibly providing context for setting realistic patient expectations regarding the spectrum of response.
The Potential of Altering the Gut Microbiome for Brain Health
January 11th 2020Daniel Lowenstein, MD, professor of neurology and executive vice chancellor and provost at the University of California, San Francisco, discussed the ongoing trials and steps being taken to turn the gut microbiome into a realistic therapeutic option for patients with epilepsy.
Cleveland Clinic Names Epilepsy Specialist as Inaugural Chief Research Information Officer
January 9th 2020Lara Jehi, MD, professor of neurology and co-director of Network Capacity for the Clinical and Translational Science Collaborative of Cleveland Clinic, has been appointed as the inaugural chief research information officer.
New Relapsing MS Trial Seeks to Compare Stem Cell Transplant With Biologic Drugs
January 7th 2020The trial will determine whether autologous hematopoietic stem cell transplantation is a more appropriate treatment option for patients with severe forms of relapsing MS compared to currently available biologic drugs.